Publications for Michael Murray
Publications for Michael Murray
2014
2016
Toh, D., Limenta, L., Yee, J., Wang, L., Goh, B.,
Murray, M., Lee, E. (2014). Effect of mushroom
diet on pharmacokinetics of gabapentin in
healthy Chinese subjects. British Journal of
Clinical Pharmacology, 78(1), 129-134. <a
href="http://dx.doi.org/10.1111/bcp.12273">[Mo
re Information]</a>
Chan, T., Cheung, F., Zheng, J., Lu, X., Zhu, L.,
Grewal, T., Murray, M., Zhou, F. (2016). Casein
Kinase 2 Is a Novel Regulator of the Human
Organic Anion Transporting Polypeptide 1A2
(OATP1A2) Trafficking. Molecular
Pharmaceutics, 13(1), 144-154. <a
href="http://dx.doi.org/10.1021/acs.molpharmac
eut.5b00576">[More Information]</a>
2015
Murray, M., Hraiki, A., Bebawy, M., Pazderka,
C., Rawling, T. (2015). Anti-tumor activities of
lipids and lipid analogues and their development
as potential anticancer drugs. Pharmacology &
Therapeutics, 150, 109-128. <a
href="http://dx.doi.org/10.1016/j.pharmthera.201
5.01.008">[More Information]</a>
Gillani, T., Rawling, T., Murray, M. (2015).
Cytochrome P450-Mediated Biotransformation
of Sorafenib and Its N-Oxide Metabolite:
Implications for Cell Viability and Human
Toxicity. Chemical Research in Toxicology,
28(1), 92-102. <a
href="http://dx.doi.org/10.1021/tx500373g">[M
ore Information]</a>
Yung, R., Rawling, T., Murray, M., Ching, L.
(2015). Liquid chromatography-tandem mass
spectrometry assay suitable for quantifying
omega-3 epoxy-fatty acid analogs in mouse brain
and plasma. Journal of Liquid Chromatography
and Related Technologies, 38(8), 891-897. <a
href="http://dx.doi.org/10.1080/10826076.2014.
982870">[More Information]</a>
Hannam, S., Murray, M., Romani, L., Tuicakau,
M., Whitfeld, M. (2014). Kava dermopathy in
Fiji: an acquired ichthyosis? International
Journal Of Dermatology, 53(12), 1490-1494. <a
href="http://dx.doi.org/10.1111/ijd.12546">[Mor
e Information]</a>
Murray, M., Dyari, H., Allison, S., Rawling, T.
(2014). Lipid analogues as potential drugs for the
regulation of mitochondrial cell death. British
Journal of Pharmacology, 171(8), 2051-2066. <a
href="http://dx.doi.org/10.1111/bph.12417">[Mo
re Information]</a>
Zheng, J., Chan, T., Cheung, F., Zhu, L., Murray,
M., Zhou, F. (2014). PDZK1 and NHERF1
Regulate the Function of Human Organic Anion
Transporting Polypeptide 1A2 (OATP1A2) by
Modulating Its Subcellular Trafficking and
Stability. PloS One, 9(4). <a
href="http://dx.doi.org/10.1371/journal.pone.009
4712">[More Information]</a>
Johnston, R., Rawling, T., Chan, T., Zhou, F.,
Murray, M. (2014). Selective Inhibition of
Human Solute Carrier Transporters by
Multikinase Inhibitors. Drug Metabolism and
Disposition, 42(11), 1851-1857. <a
href="http://dx.doi.org/10.1124/dmd.114.059097
">[More Information]</a>
Allison, S., Petrovic, N., Mackenzie, P., Murray,
M. (2015). Pro-migratory actions of the
prostacyclin receptor in human breast cancer
cells that over-express cyclooxygenase-2.
Biochemical Pharmacology, 96(4), 306-314. <a
href="http://dx.doi.org/10.1016/j.bcp.2015.06.00
2">[More Information]</a>
Dyari, H., Rawling, T., Bourget, K., Murray, M.
(2014). Synthetic W-3 Epoxyfatty Acids As
Antiproliferative and Pro-apoptotic Agents in
Human Breast Cancer Cells. Journal of
Medicinal Chemistry, 57(17), 7459-7464. <a
href="http://dx.doi.org/10.1021/jm501083y">[M
ore Information]</a>
Hoang, K., Allison, S., Murray, M., Petrovic, N.
(2015). Prostanoids regulate angiogenesis acting
primarily on IP and EP4 receptors.
Microvascular research, 101, 127-134. <a
href="http://dx.doi.org/10.1016/j.mvr.2015.07.00
4">[More Information]</a>
Gu, R., Hibbs, D., Ong, J., Edwards, R., Murray,
M. (2014). The multikinase inhibitor axitinib is a
potent inhibitor of human CYP1A2. Biochemical
Pharmacology, 88(2), 245-252. <a
href="http://dx.doi.org/10.1016/j.bcp.2014.01.01
6">[More Information]</a>
Chan, T., Zheng, J., Zhu, L., Grewal, T., Murray,
M., Zhou, F. (2015). Putative Transmembrane
Domain 6 of the Human Organic Anion
Transporting Polypeptide 1A2 (OATP1A2)
Influences Transporter Substrate Binding,
Protein Trafficking, and Quality Control.
Molecular Pharmaceutics, 12(1), 111-119. <a
href="http://dx.doi.org/10.1021/mp500459b">[
More Information]</a>
Murray, M. (2014). ω-3 polyunsaturated fatty
acids and their metabolites as inhibitors of
mammalian tumorigenesis. Phytochemistry
Reviews, 13(1), 139-156. <a
href="http://dx.doi.org/10.1007/s11101-013-929
4-4">[More Information]</a>
2013
Cui, P., Rawling, T., Gillani, T., Bourget, K.,
Publications for Michael Murray
Wang, X., Zhou, F., Murray, M. (2013).
Anti-proliferative actions of
N'-desmethylsorafenib in human breast cancer
cells. Biochemical Pharmacology, 86(3),
419-427. <a
href="http://dx.doi.org/10.1016/j.bcp.2013.05.01
4">[More Information]</a>
Zhou, F., Zheng, J., Zhu, L., Jodal, A., Cui, P.,
Wong, K., Gurney, H., Church, W., Murray, M.
(2013). Functional Analysis of Novel
Polymorphisms in the Human SLCO1A2 Gene
that Encodes the Transporter OATP1A2. The
AAPS Journal, 15(4), 1099-1108. <a
href="http://dx.doi.org/10.1208/s12248-013-951
5-1">[More Information]</a>
Toh, D., Cheung, F., Murray, M., Pern, T., Lee,
E., Zhou, F. (2013). Functional Analysis of
Novel Variants in the Organic
Cation/Ergothioneine Transporter 1 Identified in
Singapore Populations. Molecular
Pharmaceutics, 10(7), 2509-2516. <a
href="http://dx.doi.org/10.1021/mp400193r">[M
ore Information]</a>
Ghassabian, S., Murray, M. (2013).
Simultaneous In Vivo Phenotyping of CYP
Enzymes. In Phillips, Ian R.; Shephard,
Elizabeth A.; Ortiz de Montellano, Paul R (Eds.),
Cytochrome P450 Protocols, (pp. 261-267). New
York: Springer.
2012
Cui, P., Rawling, T., Bourget, K., Kim, T., Duke,
C., Doddareddy, M., Hibbs, D., Zhou, F.,
Tattam, B., Petrovic, N., Murray, M. (2012).
Antiproliferative and Antimigratory Actions of
Synthetic Long Chain n-3 Monounsaturated
Fatty Acids in Breast Cancer Cells That
Overexpress Cyclooxygenase-2. Journal of
Medicinal Chemistry, 55(16), 7163-7172. <a
href="http://dx.doi.org/10.1021/jm300673z">[M
ore Information]</a>
Armour, C., Chaar, B., Murray, M., Ambler, G.,
Krass, I. (2012). Current therapies and pharmacy
programs for obesity and diabetes. In Louise A.
Baur, Stephen M. Twigg, Roger S.Magnusson
(Eds.), A Modern Epidemic: Expert Perspectives
on Obesity and Diabetes, (pp. 315-338). Sydney,
Australia: Sydney University Press.
Murray, M. (2012). Introduction and Overview.
In Pavel Anzenbacher and Ulrich M Zanger
(Eds.), Metabolism of Drugs and Other
Xenobiotics, (pp. 519-542). Weinheim: Wiley V C H Verlag GmbH & Co. KGaA.
Ghassabian, S., Rawling, T., Zhou, F.,
Doddareddy, M., Tattam, B., Hibbs, D.,
Edwards, R., Cui, P., Murray, M. (2012). Role of
human CYP3A4 in the biotransformation of
sorafenib to its major oxidized metabolites.
Biochemical Pharmacology, 84(2), 215-223. <a
href="http://dx.doi.org/10.1016/j.bcp.2012.04.00
1">[More Information]</a>
Rawling, T., McDonagh, A., Tattam, B., Murray,
M. (2012). Synthesis of unsymmetrical biaryl
ureas from N-carbamoylimidazoles: kinetics and
application. Tetrahedron, 68(30), 6065-6070. <a
href="http://dx.doi.org/10.1016/j.tet.2012.05.002
">[More Information]</a>
Murray, M. (2012). Toxicological actions of
plant-derived and anthropogenic
methylenedioxyphenyl-substituted chemicals in
mammals and insects. Journal of Toxicology and
Environmental Health. Part B: Critical Reviews,
15(6), 365-395. <a
href="http://dx.doi.org/10.1080/10937404.2012.
705105">[More Information]</a>
2011
Toh, S., Murray, M., Tan, K., Mulay, V.,
Grewal, T., Lee, E., Zhou, F. (2011). Functional
analysis of pharmacogenetic variants of human
organic cation/carnitine transporter 2 (hOCTN2)
identified in Singaporean populations.
Biochemical Pharmacology, 82(11), 1692-1699.
<a
href="http://dx.doi.org/10.1016/j.bcp.2011.08.00
8">[More Information]</a>
Zhou, F., Lee, A., Krafczyk, K., Zhu, L., Murray,
M. (2011). Protein Kinase C Regulates the
Internalization and Function of the Human
Organic Anion Transporting Polypeptide 1A2.
British Journal of Pharmacology, 162(6),
1380-1388. <a
href="http://dx.doi.org/10.1111/j.1476-5381.201
0.01144.x">[More Information]</a>
Cui, P., Petrovic, N., Murray, M. (2011). The
w-3 Epoxide of Eicosapentaenoic Acid Inhibits
Endothelial Cell Proliferation by p38 MAP
Kinase Activation and Cyclin D1/CDK4
Down-Regulation. British Journal of
Pharmacology, 162(5), 1143-1155. <a
href="http://dx.doi.org/10.1111/j.1476-5381.201
0.01113.x">[More Information]</a>
2010
Rong, X., Li, Y., Ebihara, K., Zhao, M.,
Naowaboot, J., Kusakabe, T., Kuwahara, K.,
Murray, M., Nakao, K. (2010). Angiotensin II
type 1 receptor-independent beneficial effects of
telmisartan on dietary-induced obesity, insulin
resistance and fatty liver in mice. Diabetologia,
53, 1727-1731. <a
href="http://dx.doi.org/10.1007/s00125-010-174
4-6">[More Information]</a>
Murray, M. (2010). Cytochromes P450: Roles in
the Biotransformation of Chemicals in Cigarette
Smoke and Impact of Smoking Cessation on
Concurrent Drug Therapy. Journal of Smoking
Publications for Michael Murray
Cessation, 5(2), 107-114. <a
href="http://dx.doi.org/10.1375/jsc.5.2.107">[M
ore Information]</a>
Rawling, T., Duke, C., Cui, P., Murray, M.
(2010). Facile and Stereoselective Synthesis of
(Z)-15-Octadecenoic Acid and
(Z)-16-Nonadecenoic Acid: Monounsaturated
Omega-3 Fatty Acids. Lipids, 45(2), 159-165. <a
href="http://dx.doi.org/10.1007/s11745-009-337
8-3">[More Information]</a>
Zhou, F., Zhu, L., Cui, P., Church, W., Murray,
M. (2010). Functional characterization of
nonsynonymous single nucleotide
polymorphisms in the human organic anion
transporter 4 (hOAT4). British Journal of
Pharmacology, 159, 419-427. <a
href="http://dx.doi.org/10.1111/j.1476-5381.200
9.00545.x">[More Information]</a>
Toh, S., Yee, J., Koo, S., Murray, M., Lee, E.
(2010). Genetic Variations of the SLC22A5
Gene in the Chinese and Indian Populations of
Singapore. Drug Metabolism and
Pharmacokinetics, 25(1), 112-119. <a
href="http://dx.doi.org/10.2133/dmpk.25.112">[
More Information]</a>
D'Esposito, F., Nebot, N., Edwards, R., Murray,
M. (2010). Impaired irinotecan biotransformation
in hepatic microsomal fractions from patients
with chronic liver disease. British Journal of
Clinical Pharmacology, 70(3), 400-408. <a
href="http://dx.doi.org/10.1111/j.1365-2125.201
0.03715.x">[More Information]</a>
Cui, P., Lee, A., Zhou, F., Murray, M. (2010).
Impaired transactivation of the human CYP2J2
arachidonic acid epoxygenase gene in HepG2
cells subjected to nitrative stress. British Journal
of Pharmacology, 159(7), 1440-1449. <a
href="http://dx.doi.org/10.1111/j.1476-5381.200
9.00628.x">[More Information]</a>
Rong, X., Li, Y., Ebihara, K., Zhao, M.,
Kusakabe, T., Tomita, T., Murray, M., Nakao, K.
(2010). Irbesartan treatment up-regulates hepatic
expression of PPARalpha and its target genes in
obese Koletsky (fa(k)/fa(k)) rats: a link to
amelioration of hypertriglyceridaemia. British
Journal of Pharmacology, 160(7), 1796-1807. <a
href="http://dx.doi.org/10.1111/j.1476-5381.201
0.00835.x">[More Information]</a>
Nebot, N., Crettol, S., D'Esposito, F., Tattam, B.,
Hibbs, D., Murray, M. (2010). Participation of
CYP2C8 and CYP3A4 in the N-demethylation of
imatinib in human hepatic microsomes. British
Journal of Pharmacology, 161(5), 1059-1069. <a
href="http://dx.doi.org/10.1111/j.1476-5381.201
0.00946.x">[More Information]</a>
Crettol, S., Petrovic, N., Murray, M. (2010).
Pharmacogenetics of phase I and phase II drug
metabolism. Current Pharmaceutical Design,
16(2), 204-219. <a
href="http://dx.doi.org/10.2174/1381612107901
12674">[More Information]</a>
Murray, M., Cui, P., Zhou, F. (2010). Roles of
Mitogen-Activated Protein Kinases in the
Regulation of CYP Genes. Current Drug
Metabolism, 11(10), 850-858. <a
href="http://dx.doi.org/10.2174/1389200107944
79664">[More Information]</a>
Ghassabian, S., Chetty, M., Tattam, B., Glen, J.,
Rahme, J., Stankovic, Z., Ramzan, I., Murray,
M., McLachlan, A. (2010). The participation of
cytochrome P450 3A4 in clozapine
biotransformation is detected in people with
schizophrenia by high-throughput in vivo
phenotyping. Journal of Clinical
Psychopharmacology, 30(5), 629-631. <a
href="http://dx.doi.org/10.1097/JCP.0b013e3181
f03e30">[More Information]</a>
Lee, A., Murray, M. (2010). Up-Regulation of
Human CYP2J2 in HepG2 Cells by Butylated
Hydroxyanisole Is Mediated by c-Jun and Nrf2.
Molecular Pharmacology, 77(6), 987-994. <a
href="http://dx.doi.org/10.1124/mol.109.062729
">[More Information]</a>
Petrovic, N., Murray, M. (2010). Using
N,N,N',N'-tetramethyl-p-phenylenediamine
(TMPD) to assay cyclooxygenase activity in
vitro. In Donald Armstrong (Eds.), Methods in
Molecular Biology: Advanced Protocols in
Oxidative Stress II, (pp. 129-140). New York
USA: Humana Press.
Li, Y., Saito, Y., Kuwahara, K., Rong, X.,
Kishimoto, I., Harada, M., Horiuchi, M., Murray,
M., Nakao, K. (2010). Vasodilator therapy with
hydralazine induces
angiotensin AT2 receptor-mediated
cardiomyocyte
growth in mice lacking guanylyl cyclase-A.
British Journal of Pharmacology, 159,
1133-1142. <a
href="http://dx.doi.org/10.1111/j.1476-5381.200
9.00619.x">[More Information]</a>
2009
Ghassabian, S., Chetty, M., Tattam, B., Glen, J.,
Rahme, J., Stankovic, Z., Ramzan, I., Murray,
M., McLachlan, A. (2009). A high-throughput
assay using liquid chromatography-tandem mass
spectrometry for simultaneous in vivo
phenotyping of 5 major cytochrome p450
enzymes in patients. Therapeutic Drug
Monitoring, 31(2), 239-246. <a
href="http://dx.doi.org/10.1097/FTD.0b013e318
197e1bf">[More Information]</a>
Rong, X., Li, Y., Ebihara, K., Zhao, M., Aini,
Publications for Michael Murray
W., Kusakabe, T., Hirata, M., Miyamoto, L.,
Murray, M., Nakao, K. (2009). An Adipose
Tissue-Independent Insulin-Sensitizing Action of
Telmisartan: a Study in Lipodystrophic Mice.
Journal of Pharmacology and Experimental
Therapeutics, 331(3), 1096-1103. <a
href="http://dx.doi.org/10.1124/jpet.109.157099"
>[More Information]</a>
Toh, S., Koo, S., Limenta, L., Yee, J., Murray,
M., Lee, E. (2009). Genetic Variations of the
SLC22A4 Gene in Chinese and Indian
Populations of Singapore. Drug Metabolism and
Pharmacokinetics, 24(5), 475-481. <a
href="http://dx.doi.org/10.2133/dmpk.24.475">[
More Information]</a>
Li, Y., Saito, Y., Kuwahara, K., Rong, X.,
Kishimoto, I., Harada, M., Adachi, Y.,
Nakanishi, M., Kinoshita, H., Horiuchi, M.,
Murray, M., et al (2009). Guanylyl Cyclase-A
Inhibits Angiotensin II Type 2
Receptor-Mediated Pro-Hypertrophic Signaling
in the Heart. Endocrinology, 150(8), 3759-3765.
<a
href="http://dx.doi.org/10.1210/en.2008-1353">[
More Information]</a>
Chetty, M., D'Esposito, F., Zhang, W., Glen, J.,
Dore, G., Stankovic, Z., Edwards, R., Ramzan,
I., Murray, M. (2009). In vitro and in vivo
evaluation of the inhibition potential of
risperidone toward clozapine biotransformation.
British Journal of Clinical Pharmacology, 68(4),
574-579. <a
href="http://dx.doi.org/10.1111/j.1365-2125.200
9.03476.x">[More Information]</a>
Xu, H., Murray, M., McLachlan, A. (2009).
Influence of Genetic Polymorphisms on the
Pharmacokinetics and Pharmacodynamics of
Sulfonylurea Drugs. Current Drug Metabolism,
10(6), 643-658. <a
href="http://dx.doi.org/10.2174/1389200097893
75388">[More Information]</a>
Cui, P., Zhang, W., Hook, J., Tattam, B., Duke,
C., Murray, M. (2009). Synthesis and NMR
characterization of the methyl esters of
eicosapentaenoic acid monoepoxides. Chemistry
and Physics of Lipids, 159(1), 30-37. <a
href="http://dx.doi.org/10.1016/j.chemphyslip.20
09.02.005">[More Information]</a>
Millar, A., Qi, Y., Rong, X., Jiang, J., Yang, Q.,
Yamahara, J., Murray, M., Li, Y. (2009). The
Ayurvedic medicine Salacia oblonga attenuates
diabetic renal fibrosis in rats: suppression of
angiotensin II/AT1 signaling. Evidence-Based
Complementary and Alternative Medicine, , 1 of
13-13 of 13. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=19706694">[More Information]</a>
2008
D'Esposito, F., Tattam, B., Ramzan, I., Murray,
M. (2008). A liquid chromatography/electrospray
ionization mass spectrometry (LC-MS/MS) assay
for the determination of irinotecan (CPT-11) and
its two major metabolites in human liver
microsomal incubations and human plasma
samples. Journal of Chromatography. B,
Analytical Technologies in the Biomedical and
Life Sciences, 875(2), 522-530. <a
href="http://dx.doi.org/10.1016/j.jchromb.2008.1
0.011">[More Information]</a>
Rong, X., Kim, M., Su, N., Wen, S., Matsuo, Y.,
Yamahara, J., Murray, M., Li, Y. (2008). An
aqueous extract of Salacia oblonga root, a
herb-derived peroxisome proliferator-activated
receptor-alpha activator, by oral gavage over 28
days induces gender-dependent hepatic
hypertrophy in rats. Food and Chemical
Toxicology, 46(6), 2165-2172. <a
href="http://dx.doi.org/10.1016/j.fct.2008.02.022
">[More Information]</a>
Xu, H., Williams, K., Liauw, W., Murray, M.,
Day, R., McLachlan, A. (2008). Effects of St
John's wort and CYP2C9 genotype on the
pharmacokinetics and pharmacodynamics of
gliclazide. British Journal of Pharmacology,
153(7), 1579-1586. <a
href="http://dx.doi.org/10.1038/sj.bjp.0707685">
[More Information]</a>
Li, Y., Qi, Y., Kim, M., Zhe-Yang Xu, K.,
Huang, H., Rong, X., Murray, M., Yamahara, J.
(2008). Increased renal collagen cross-linking
and lipid accumulation in nephropathy of Zucker
diabetic fatty rats. Diabetes - Metabolism:
Research and Reviews, 24(6), 498-506. <a
href="http://dx.doi.org/10.1002/dmrr.874">[Mor
e Information]</a>
Zhang, W., D'Esposito, F., Edwards, R., Ramzan,
I., Murray, M. (2008). Interindividual Variation
in Relative CYP1A2/3A4 Phenotype Influences
Susceptibility of Clozapine Oxidation to
Cytochrome P450-Specific Inhibition in Human
Hepatic Microsomes. Drug Metabolism and
Disposition, 36(12), 2547-2555. <a
href="http://dx.doi.org/10.1124/dmd.108.023671
">[More Information]</a>
Szymczak, M., Murray, M., Petrovic, N. (2008).
Modulation of angiogenesis by omega-3
polyunsaturated fatty acids is mediated by
cyclooxygenases. Blood, 111(7), 3514-3521. <a
href="http://dx.doi.org/10.1182/blood-2007-08-1
09934">[More Information]</a>
Murray, M. (2008). Modulation of Cytochromes
P450 by Phytochemicals. In Costas Ioannides
(Eds.), Cytochromes P450: Role in the
Metabolism and Toxicity of Drugs and other
Xenobiotics, (pp. 449-479). UK: RSC
Publications for Michael Murray
Publishing.
Petrovic, N., Murray, M. (2008). Modulation of
Tumor Angiogenesis by Polyunsaturated Fatty
Acids: What is the Mechanism? In Peter B.
Murphy and Jason R. Clarke (Eds.), Oncogene
Proteins: Structure, Functions and Analyses, (pp.
117-138). USA: Nova Science Publishers.
2007
the Study of Xenobiotics) Meeting, United States:
Informa Healthcare.
Murray, M. (2006). Altered CYP expression and
function in response to dietary factors: potential
roles in disease pathogenesis. Current Drug
Metabolism, 7(1), 67-81. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16454693">[More Information]</a>
Shankar, G., Charleston, M., Murray, M., Hibbs,
D. (2007). A structural and phylogenetic analysis
of cytochrome P450. In Damjana Rozman
(Eds.), Proceedings of the 15th International
Conference on Cytochromes P450:
Biochemistry, Biophysics and Functional
Genomics, (pp. 75-80). Bologna, Italy:
Medimond.
Murray, M., Petrovic, N. (2006). Cytochromes
P450: Decision-making tools for personalized
therapeutics. Current Opinion in Molecular
Therapeutics, 8(6), 480-486. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17243482">[More Information]</a>
Chetty, M., Murray, M. (2007). CYP-mediated
clozapine interactions: how predictable are they?
Current Drug Metabolism, 8(4), 307-313. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17504220">[More Information]</a>
D'Esposito, F., Tattam, B., Ramzan, I., Murray,
M. (2006). Development of a high throughput
LC/MS/MS method for the determination of the
anticancer agent irinotecan and its two major
metabolites. Australian Health and Medical
Research Congress, Melbourne: Australian
Health and Medical Research Congress.
Zhang, W., Ramzan, I., Murray, M. (2007).
Impaired microsomal oxidation of the atypical
antipsychotic agent clozapine in hepatic
steatosis. Journal of Pharmacology and
Experimental Therapeutics, 322(2), 770-777. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17522342">[More Information]</a>
Obligacion, R., Murray, M., Ramzan, I. (2006).
Drug-Metabolizing Enzymes and Review
Transporters: Expression in the Human Prostate
and Roles in Prostate Drug Disposition. Journal
Of Andrology, 27(2), 138-150. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16330661">[More Information]</a>
Fiala-Beer, E., Lee, A., Murray, M. (2007).
Regulation of the rat CYP4A2 gene promoter by
c-Jun and octamer binding protein-1. The
International Journal of Biochemistry and Cell
Biology, 39(6), 1235-1247. <a
href="http://dx.doi.org/10.1016/j.biocel.2007.03.
019">[More Information]</a>
Cowpland, C., Quee, G., Murray, M., Puddey, I.,
Croft, K. (2006). Effect of alcohol on
cytochrome P450 arachidonic acid metabolism
and blood pressure in rats and its modulation by
red wine polyphenolics. Clinical and
Experimental Pharmacology and Physiology,
33(3), 183-188. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16487260">[More Information]</a>
Murray, M. (2007). Role of signalling systems in
the effects of dietary factors on the expression of
mammalian CYPs. Expert Opinion on Drug
Metabolism and Toxicology, 3(2), 185-196. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17428150">[More Information]</a>
2006
Murray, M., Zhang, W., Duke, C., Ramzan, I.
(2006). Accumulation of esterified
polyunsaturated fatty acids in hepatic steatosis
impairs microsomal clozapine oxidation.
Australian Health and Medical Research
Congress, Melbourne: Australian Health and
Medical Research Congress.
Murray, M., Marden, N., Lee, A. (2006). Altered
CYP expression and function by dietary factors:
Potential roles in disease pathogenesis. 14th
North American ISSX (International Society for
Murray, M., Zhang, W., Ramzan, I. (2006).
Hepatic lipid accumulation in experimental
steatosis influences microsomal clozapine
oxidation capacity.
Murray, M., Zhang, W., Ramzan, I. (2006).
Hepatic lipid accumulation in experimental
steatosis influences microsomal clozapine
oxidation capacity. 14th North American ISSX
(International Society for the Study of
Xenobiotics) Meeting, United States: Informa
Healthcare.
Shankar, G., Charleston, M., Murray, M., Hibbs,
D. (2006). Phylogenetic analysis of cytochrome
P450 structures. BIOINFORMATICS
AUSTRALIA 2006, Sydney: NSW Office for
Science and Medical Research.
Publications for Michael Murray
Murray, M. (2006). Role of CYP
pharmacogenetics and drug-drug interactions in
the efficacy and safety of atypical and other
antipsychotic agents. Journal of Pharmacy and
Pharmacology, 58(7), 871-885. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16805946">[More Information]</a>
2005
Marden, N., Murray, M. (2005). Characterization
of a c-Jun-responsive module in the 5'-flank of
the human CYP2J2 gene that regulates
transactivation. Biochemical Journal, 391(3),
631-640. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16008525">[More Information]</a>
Murray, M., Butler, A., Fiala-Beer, E., Su, G.
(2005). Phospho-STAT5 accumulation in nuclear
fractions from vitamin A-deficient rat liver.
FEBS Letters, 579(17), 3669-3673. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15963505">[More Information]</a>
Lee, A., Marden, N., Murray, M. (2005).
Potential transcriptional control elements in the
5'-upstream region of the human CYP2J2 gene.
Australasian Society of Clinical and
Experimental Pharmacologists and Toxicologists
Conference. World Scientific Publishing.
Su, G., Fiala-Beer, E., Weber, J., Jahn, D.,
Robertson, G., Murray, M. (2005).
Pretranslational upregulation of microsomal
CYP4A in rat liver by intake of a high-sucrose,
lipid-devoid diet containing orotic acid.
Biochemical Pharmacology, 69(4), 709-717. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15670589">[More Information]</a>
Liu, L., Murray, M., Conlon, J., Burcher, E.
(2005). Quantitative Structure-Activity analyses
of bufokinin and other tachykinins at bufokinin
(bNK1) receptors of the small intestine of the can
toad, Bufo marinus. Biochemical Pharmacology,
69(2), 329-338. <a
href="http://dx.doi.org/10.1016/j.bcp.2004.09.02
3">[More Information]</a>
Murray, M., Fiala-Beer, E. (2005). Role of c-Jun
in the transcriptional activation of the rat
cytochrome P450 (CYP) 4A2. Australasian
Society of Clinical and Experimental
Pharmacologists and Toxicologists Conference.
World Scientific Publishing.
Ghassabian, S., Murray, M., Chetty, M., Glen, J.
(2005). The impact of Valproate on Plasma
Concentrations of Clozapine nad Its Major
Metabolites in Patients with Schizophrenia. Joint
Meeting of Ascept and Apsa, Melbourne:
Australian Society of Clinical and experimental
Pharmacologists and Toxicologista.
2004
Marden, N., Murray, M. (2004). Characterisation
of a c-jun-responsive module in the 5'-flank of
the human CYP2J2 gene that regulates
expression. Australian Health and Medical
Research Congress, Melbourne: Australian
Health and Medical Research Congress.
Murray, M., Butler, A. (2004). Comparative
Inhibition Of Inducible And Constitutive Cyps In
Rat Hepatic Microsomes By Parathion.
Xenobiotica, 34(8), 723-739.
Liu, L., Markus, I., Vandenberg, R., Neilan, B.,
Murray, M., Burcher, E. (2004). Molecular
Identification And Characterization Of Three
Isoforms Of Tachykinin Nk(1)-Like Receptors In
The Cane Toad Bufo Marinus. American Journal
of Physiology: Regulatory, Integrative and
Comparative Physiology, 287(3), R575-R585.
2003
Murray, M., Fiala-Beer, E., Weber, J.,
Robertson, C., Farrell, G., Su, G. (2003).
Activation of PPAR�?� is required for
upregulation of CYP4A in hepatic steatosis
induced by orotic acid. Australasian Society of
Clinical and Experimental Pharmacologists and
Toxicologists Conference. World Scientific
Publishing.
Liu, L., Markus, I., Vandenberg, R., Murray, M.,
Burcher, E. (2003). Distribution, expression and
functional activity of three tachykinin NK1
receptor isoforms from Bufo Marinus. Society
for Neuroscience, Washington DC: Society for
Neuroscience.
Murray, M., Murray, K. (2003).
Mechanism-based inhibition of CYP activities in
rat liver by fluoxetine and structurally similar
alkylamines. Xenobiotica, 33(10), 973-987.
Murray, M. (2003). Pharmacogenetic variation in
drug oxidizing CYPs: impact on drug therapy,
drug safety and drug interactions.
Pharmacogenomics and Personalized Medicine,
1(3), 159-173.
Marden, N., Murray, M. (2003). Regulation of
human cytochrome P450 2J2 by small Maf
proteins and Nrf3. Australasian Society of
Clinical and Experimental Pharmacologists and
Toxicologists Conference. World Scientific
Publishing.
Marden, N., Fiala-Beer, E., XIANG, S., Murray,
M. (2003). Role of activator protein-1 in the
down-regulation of the human CYP2J2 gene in
hypoxia. Biochemical Journal, 373(3), 669-680.
Publications for Michael Murray
Murray, M., Fiala-Beer, E., Sutton, D. (2003).
Upregulation of cytochromes P450 2B in rat
liver by orphenadrine. British Journal of
Pharmacology, 139(4), 787-796.
orotic acid-induced steatosis. Proceedings of the
Australian Health and Medical Research
Congress 2002, : British Medical Journal
Publishing Group.
2002
2001
Liu, L., Markus, I., Neilan, B., Murray, M.,
Burcher, E. (2002). Cloning of bufokinin
(tachykinin) receptors from the toad brain.
Australian Neuroscience Society 23rd Annual
Meeting, Burlington, MA: Academic Press.
Hoskins, J., Shenfield, G., Murray, M., Gross, A.
(2001). Characterization of moclobemide
N-oxidation in
Stupans, I., Tan, H., Kirlich, A., Tuck, K.,
Hayball, P., Murray, M. (2002). Inhibition of
CYP3A-mediated oxidation in human hepatic
microsomes by the dietary derived complex
phenol, gallic acid. Journal of Pharmacy and
Pharmacology, 54, 269-275.
Liu, L., Markus, I., Murray, M., Neilan, B.,
Burcher, E. (2002). Multiple isoforms of
tachykinin NK1 receptor in toad gut and brain.
Proceedings of the Australian Health and
Medical Research Congress 2002, : British
Medical Journal Publishing Group.
Anggono, V., Marden, N., Murray, M. (2002).
Nitric Oxide down regulates cytochrome P450
2J2 via mitogen-activated protein kinase
pathways. Proceedings of the Australian Health
and Medical Research Congress 2002, : British
Medical Journal Publishing Group.
Su, G., Fiala-Beer, E., Murray, M. (2002).
Regulation of SOCS genes in vitamin A deficient
rat liver. Proceedings of the Australian Health
and Medical Research Congress 2002, : British
Medical Journal Publishing Group.
Marden, N., XIANG, S., Murray, M. (2002).
Role of AP-1 in the regulation of human
cytochrome P450 2J2 in hypoxia. Proceedings of
the Australian Health and Medical Research
Congress 2002, : British Medical Journal
Publishing Group.
Liu, L., Murray, M., Burcher, E. (2002).
Structure-activity studies of bufokinin, substance
P and their C-terminal fragments at bufokinin
receptors in the small intestine of the cane toad,
Bufo marinus. Biochemical Pharmacology,
63(2), 217-224.
Murray, M. (2002). Toxicology. British
Toxicological Society meeting, Ireland: Elsevier.
Murray, M., Marden, N., Anggono, V., XIANG,
S., Fiala-Beer, E. (2002). Transcriptional
regulation of endobiotic oxidising cytochromes
P450. Proceedings of the Australian Health and
Medical Research Congress 2002, : British
Medical Journal Publishing Group.
Murray, M., Fiala-Beer, E., Sefton, R., Su, G.
(2002). Upregulation of CYPs 4A in microsomal
and plasma membrane fractions from rats with
human liver microsomes. Xenobiotica, 31(7),
387-397.
Murray, M., Sefton, R., Croft, K., Butler, A.
(2001). Differential regulation of
endobiotic-oxidizing cytochromes P450 in
vitamin A-deficient male rat liver. British
Journal of Pharmacology, 134(7), 1487-1497.
Su, G., Fiala-Beer, E., Murray, M. (2001).
Dysregulation of the tyrosine phosphatase SHP-1
in Vitamin A-deficient rat liver. Australian
Society for Medical Research Meeting, Sydney,
NSW, Australia: The Australian Society for
Medical Research.
Stupans, I., Murray, M., Kirlich, A., Tuck, K.,
Hayball, P. (2001). Inactivation of cytochrome
P450 by the food-derived complex phenol
oleuropein. Food and Chemical Toxicology, 39,
1119-1124.